This company owns a popular pain reliever that can be found in over 100 countries. It claims that the pain reliever is “arguably the world’s leading and most versatile topical analgesic brand”. However, despite being a well-known healthcare brand the world over, the COVID-19 pandemic affected the company, with its overall revenue falling considerably. Having said that, I believe the company can bounce back strongly in time to come. The company is also one of the stocks that didn’t cut its dividend despite the headwinds from COVID-19. This speaks well of management’s confidence in its business for the long run. Source: Giphy For the month of September, we are introducing Haw Par Corporation Ltd (SGX: H02) as a Singapore stock you can consider buying for the long term. Haw Par owns the well-known Tiger Balm brand and it also has strategic stakes in two other Singapore-listed companies – United Overseas Bank Ltd (SGX: U11) and UOL Group Limited (SGX: U14)....